Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Carnaghi

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
ESMO Open|August 2, 2017
Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM)Lisa Salvatore, Giuseppe Aprile, Ermenegildo Arnoldi, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2010
Clinical outcome of hypofractionated stereotactic radiotherapy for abdominal lymph node metastasesMario Bignardi, Piera Navarria, Pietro Mancosu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 20, 2006
Long-term, tunneled, noncuffed central venous catheter in cancer patients (Vygon): safety, efficacy, and complicationsGiovanna Masci, Massimo Magagnoli, Vittorio Pedicini, et al.
Pancreas|February 9, 2021
Markers of Systemic Inflammation in Neuroendocrine Tumors: A Pooled Analysis of the RADIANT-3 and RADIANT-4 StudiesDavid L Chan, James C Yao, Carlo Carnaghi, et al.
Scientific Reports|February 26, 2026
Pretreatment tumor infiltrating lymphocytes and outcome in patients with HR+/HER2- advanced breast cancer treated with CDK4/6 inhibitorsRosalba Torrisi, Laura Giordano, Saverio Pancetti, et al.
Cancer|April 15, 2021
Relationship between metabolic toxicity and efficacy of everolimus in patients with neuroendocrine tumors: A pooled analysis from the randomized, phase 3 RADIANT-3 and RADIANT-4 trialsNicola Fazio, Carlo Carnaghi, Roberto Buzzoni, et al.
Investigational New Drugs|May 12, 2007
The efficacy of hybrid chemotherapy with intravenous oxaliplatin and folinic acid and intra-hepatic infusion of 5-fluorouracil in patients with colorectal liver metastases: a phase II studyCarlo Carnaghi, Armando Santoro, Lorenza Rimassa, et al.
Annals of Surgical Oncology|March 1, 2018
Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery?Luca Vigano, Shadya Sara Darwish, Lorenza Rimassa, et al.
The International Journal of Biological Markers|July 2, 2014
An exploratory biomarker study in metastatic tumors from colorectal cancer patients treated with bevacizumabFrancesco Sclafani, Lorenza Rimassa, Piergiuseppe Colombo, et al.
Frontiers in Medicine|November 25, 2024
Case report: STRN3-NTRK3 fusion in uterine sarcoma with spleen metastasis: a new variant in the spectrum of NTRK-rearranged tumorsPiergiuseppe Colombo, Giuseppina Adriana Buonamassa, Anita Giulianini, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
ESMO Open|August 2, 2017
Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM)Lisa Salvatore, Giuseppe Aprile, Ermenegildo Arnoldi, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2010
Clinical outcome of hypofractionated stereotactic radiotherapy for abdominal lymph node metastasesMario Bignardi, Piera Navarria, Pietro Mancosu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 20, 2006
Long-term, tunneled, noncuffed central venous catheter in cancer patients (Vygon): safety, efficacy, and complicationsGiovanna Masci, Massimo Magagnoli, Vittorio Pedicini, et al.
Pancreas|February 9, 2021
Markers of Systemic Inflammation in Neuroendocrine Tumors: A Pooled Analysis of the RADIANT-3 and RADIANT-4 StudiesDavid L Chan, James C Yao, Carlo Carnaghi, et al.
Scientific Reports|February 26, 2026
Pretreatment tumor infiltrating lymphocytes and outcome in patients with HR+/HER2- advanced breast cancer treated with CDK4/6 inhibitorsRosalba Torrisi, Laura Giordano, Saverio Pancetti, et al.
Cancer|April 15, 2021
Relationship between metabolic toxicity and efficacy of everolimus in patients with neuroendocrine tumors: A pooled analysis from the randomized, phase 3 RADIANT-3 and RADIANT-4 trialsNicola Fazio, Carlo Carnaghi, Roberto Buzzoni, et al.
Investigational New Drugs|May 12, 2007
The efficacy of hybrid chemotherapy with intravenous oxaliplatin and folinic acid and intra-hepatic infusion of 5-fluorouracil in patients with colorectal liver metastases: a phase II studyCarlo Carnaghi, Armando Santoro, Lorenza Rimassa, et al.
Annals of Surgical Oncology|March 1, 2018
Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery?Luca Vigano, Shadya Sara Darwish, Lorenza Rimassa, et al.
The International Journal of Biological Markers|July 2, 2014
An exploratory biomarker study in metastatic tumors from colorectal cancer patients treated with bevacizumabFrancesco Sclafani, Lorenza Rimassa, Piergiuseppe Colombo, et al.
Frontiers in Medicine|November 25, 2024
Case report: STRN3-NTRK3 fusion in uterine sarcoma with spleen metastasis: a new variant in the spectrum of NTRK-rearranged tumorsPiergiuseppe Colombo, Giuseppina Adriana Buonamassa, Anita Giulianini, et al.
Pageof 7